Detection of Minimal Residual Disease in Patients with Multiple Myeloma by PCR-Based IGH Gene Clonality Analysis Using DNA Extracted From Archival Bone Marrow Slides

被引：0
|
作者：
Takamatsu, Hiroyuki [1 ]
Ogawa, Yoshiyasu [2 ]
Kobayashi, Noriko [2 ]
Obata, Kazue [2 ]
Narisawa, Tadashi [2 ]
Nakayama, Kouji [2 ]
Nakao, Shinji [1 ]
机构：
[1] Kanazawa Univ, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan
[2] Mitsubishi Chem Medience Corp, Adv Med Sci Res Ctr, Tokyo, Japan
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：820 / 821
页数：2
相关论文
共 50 条
  • [41] Pre-transplantation level of minimal residual disease detected by quantitative real-time IgH-PCR is a prognostic parameter in patients with multiple myeloma.
    Fenk, R
    Korthals, M
    Kobbe, G
    Steidl, U
    Graef, T
    Rohr, UP
    Ruf, L
    Hoyer, B
    Neumann, F
    Haas, R
    Kronenwett, R
    BLOOD, 2004, 104 (11) : 300B - 300B
  • [42] Limitations of quantitative detection of immunoglobulin heavy chain (IgH) gene rearrangements in multiple myeloma (MM) patients using real-time PCR
    Ladetto, M
    Donovan, JW
    Schlossman, R
    Anderson, K
    Gribben, JG
    BLOOD, 1998, 92 (10) : 258A - 258A
  • [43] Baseline identification of clonal V(D)J sequences for DNA-based minimal residual disease detection in multiple myeloma
    Rustad, Even H.
    Hultcrantz, Malin
    Yellapantula, Venkata D.
    Akhlaghi, Theresia
    Ho, Caleb
    Arcila, Maria E.
    Roshal, Mikhail
    Patel, Akshar
    Chen, Denise
    Devlin, Sean M.
    Jacobsen, Austin
    Huang, Ying
    Miller, Jeffrey E.
    Papaemmanuil, Elli
    Landgren, Ola
    PLOS ONE, 2019, 14 (03):
  • [44] Minimal residual disease (MRD) analysis and identification of differences in-between subpopulations in the bone marrow (BM) of multiple myeloma (MM) patients (pts) using multiparametric flow cytometry (MFC)
    Dold, S. M.
    Bartsch, I
    Wider, D.
    Riebl, V. C.
    Mueller, S. J.
    Pantic, M.
    Miething, C.
    Kiote-Schmidt, C.
    Zlei, M.
    Azab, A. K.
    Binder, M.
    Rawluk, J.
    Ewerth, D.
    Duyste
    Zeiser, R.
    Waesch, R.
    Engelhardt, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 184 - 184
  • [45] Evaluation of hemodilution influence on bone marrow minimal residual disease (MRD) assessment in multiple myeloma patients via assessing mast cell abundance
    Wangemann, J.
    Stuebig, T.
    Sanoja-Flores, L.
    Boettcher, S.
    Chitadze, G.
    Novakova, M.
    Szczepanowski, M.
    Einsele, H.
    Kneba, M.
    Flores-Montero, J.
    Brueggemann, M.
    Ritgen, M.
    Orfao, A.
    Knop, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 104 - 104
  • [46] Effects of Exercise Training on the Bone Marrow Immune Microenvironment and Minimal Residual Disease in Multiple Myeloma Patients Following First-Line Treatment
    Spiliopoulou, Polyxeni
    Rousakis, Pantelis
    Panteli, Chrysanthi
    Eleutherakis-Papaiakovou, Evangelos
    Migkou, Magdalini
    Kanellias, Nikolaos
    Ntanasis-Stathopoulos, Ioannis
    Malandrakis, Panagiotis
    Theodorakakou, Foteini
    Fotiou, Despina
    Terpos, Evangelos
    Gavriatopoulou, Maria
    Tsitsilonis, Ourania E.
    Kastritis, Efstathios
    Dimopoulos, Meletios Athanasios
    Terzis, Gerasimos
    SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS, 2025, 35 (02)
  • [47] GENE EXPRESSION OF OSTEOBLAST REGULATORS IN WHOLE BONE MARROW SAMPLES FROM MULTIPLE MYELOMA PATIENTS IN ASSOCIATION WITH OSTEOLYTIC BONE DISEASE
    Kristensen, I.
    Haaber, J.
    Petersen, M.
    Ditzel, H.
    Abildgaard, N.
    HAEMATOLOGICA, 2012, 97 : 330 - 331
  • [48] DETECTION OF BONE-MARROW MINIMAL DISEASE IN NON-HODGKINS LYMPHOMA PATIENTS BY GENE REARRANGEMENT ANALYSIS
    BREGNI, M
    BORRELLO, MG
    SIENA, S
    ORAZI, A
    BIASSONI, D
    BONADONNA, G
    GIANNI, AM
    HAEMATOLOGICA, 1989, 74 (04) : 397 - 400
  • [49] Comparative analysis of minimal residual disease detection using four-color flow cytometry, consensus IgH-PCR, and quantitative IgH PCR in CLL after allogeneic and autologous stem cell transplantation
    S Böttcher
    M Ritgen
    C Pott
    M Brüggemann
    T Raff
    S Stilgenbauer
    H Döhner
    P Dreger
    M Kneba
    Leukemia, 2004, 18 : 1637 - 1645
  • [50] Comparative analysis of minimal residual disease detection using four-color flow cytometry, consensus IgH-PCR, and quantitative IgH PCR in CLL after allogeneic and autologous stem cell transplantation
    Böttcher, S
    Ritgen, M
    Pott, C
    Brüggemann, M
    Raff, T
    Stilgenbauer, S
    Döhner, H
    Dreger, P
    Kneba, M
    LEUKEMIA, 2004, 18 (10) : 1637 - 1645
12345